Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: tom r. phillips who wrote (85670)	11/18/2000 3:48:20 AM
From: PaperChase	Read Replies (1) \| Respond to of 132070

If VASO can actually hit its earnings projections next year, I could see someone buying them at a 15x trailing P/E. My concern (which I haven't researched at all) would be what has been the impediment to growth so far? Often it's reimbursement. ULGX is an example of a med device company that suffered for years until the reimbursement finally came thru to justify the purchase of their BPH outpatient microwave therapy device for a doctor's office. If you like the med device area you might also want to take a look at IMA (formerly Selfcare). It's richly priced right now and they have secondary offering scheduled for Nov. 21st. IMHO, if it should retrace to $20 (very possible), it would be a good buy worth evaluating. IMA is aspiring to be the next MNMD, a lofty goal that would have a nice payoff if it is accomplished. In the meantime their "bread and butter" comes from supplying J&J's Lifescan unit with the latest glucose devices and disposables.